// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























486 Abstracts

Liver Stiffness and Risk of Recurrence after Liver Resection for HCC

P. Tortajada - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Sarcopenia Is Associated with Higher AFP Levels in Patients with Hepatocellular Carcinoma (HCC)

T. Bajric - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Liver cancer

N/A

An Unusual Entity Mimicking Hepatocellular Carcinoma

V.E. Holguin - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Alfa-fetoprotein

Klastkin Mimic Lesion-Obstructive Jaundice-Rare Disease: A Case Report

S. Rahman - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Hyperbilirubinemia

N/A

Laparoscopic hepatectomy for preoperative suspected hepatocellular carcinoma: perioperative results at a single center

C.U. Marino - International Hepato-Pancreato-Biliary Association (IHPBA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Alfa-fetoprotein

Preoperative Prediction Score of Hepatocellular Carcinoma Recurrence in Living Donor Liver Transplantation: Validation of SNAPP Score Developed at Asan Medical Center

S.-H. Kim - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Alfa-fetoprotein

Changes in the Peripheral Treg Cell Proportion and Immune Function in Hepatocellular Carcinoma Patients After Transarterial Chemoembolization with Gelatin Sponge Microparticles

Y. Zhang - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Alfa-fetoprotein

Biochemical Parameters and PIVKA-II in Patients with Hepatocellular Carcinoma on Waiting List for Liver Transplantation

F. Alconchel - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Alfa-fetoprotein

Primary Neuroendocrine Tumor of the Liver

O. Coronado - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Neuroendocrine tumors

N/A

Solitary Fibrous Tumor of the Liver: Case Report

A. Cavero Ibiricu - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solitary fibrous tumor

N/A

Extended right hepatectomy with vena cava replacement for huge HCC

P. Magistri - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Laparoscopic IVA-B resection for hepatocellular carcinoma using indocyanine green guided surgery in a cirrhotic patient

C. Gómez-Gavara - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Nonalcoholic steatohepatitis

N/A

Robotic left lateral sectionectomy for hepatocellular carcinoma (HCC) on cirrhotic liver

E. Felli - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Robotic atypical resection of liver segment II for hepatocellular carcinoma (HCC) on a fibrotic (F3) liver

E. Felli - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

THE LATE INTRACRANIAL ADVERSE EVENTS OCCUR MORE FREQUENTLY IN INTRACRANIAL GERMINOMAS TREATED WITH HIGH DOSE RADIOTHERAPY

Yoshiki Arakawa - Society for Neuro-Oncology (SNO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

VAN WNK GRUMBACH SYNDROME - A DIAGNOSTIC CHALLENGE

Prajval Tovhar - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Polycystic Ovary Syndrome

N/A

TUBERCULOUS SALPINGITIS IN A 16-YEAR-OLD GIRL: A CASE REPORT

Mowjood M. Faseel - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

The feasibility of tumor recurrence detection in liver post-transplantation for patients with hepatocellular carcinoma via personalized, tumor-informed ctDNA testing

M. Abdelrahim - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Alfa-fetoprotein

Ovarian hilus cell hyperplasia: a rare cause of progressive virilization in a girl with Turner syndrome in the absence of Y chromosomal material

Y.G. van der Zwan - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Turner syndrome

Alora

Beckwith-Wiedemann Syndrome: three case reports

Joana Moscoso - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Beckwith–Wiedemann syndrome

Levothyroxine

Copyright © 2026. QuantiNova All rights reserved